The term "druggable/binding site" refers to the capacity of medications or ligands to target and bind to particular protein areas effectively. We anticipated that the aptamer would attach to a particular HER2 receptor binding site. To find the universal binding site on the receptor's surface, we employed a graph neural network (GNN) with the Graph Attention Site Prediction (GrASP)